Seldinger Technique Based Pulmonary Artery Catheterization: A Procedure to Insert Pulmonary Artery Catheter Through the Jugular Vein in a Porcine Model

Executive Industry Relevance

This procedure enables hemodynamic assessment in preclinical models, supporting target validation and mechanistic de-risking in cardiovascular drug development. Accurate pulmonary artery catheterization provides quantitative pressure measurements that inform go/no-go decisions and reduce late-stage biological risk. The technique supports translational continuity from discovery through preclinical validation.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through direct measurement of cardiac chamber pressures.
• Operational Value: Supports biological de-risking by validating functional targets in a disease-relevant porcine model.
• Predictive Value: Generates hemodynamic data that improves predictive confidence for compound evaluation.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream assay standardization and reproducibility.
• Operational Value: Facilitates quantitative dependent variable measurements essential for reliable compound screening.
• Scalability: Supports platform reuse across cardiovascular discovery workflows.

Translational & Preclinical Research

• Scientific Value: Maintains disease relevance through porcine model alignment with human cardiovascular physiology.
• Operational Value: Ensures continuity from discovery through preclinical validation via consistent pressure signal monitoring.
• Risk Mitigation: Informs risk-adjusted advancement decisions by confirming cardiopulmonary stability.

Pipeline & Workflow Integration

The method integrates into the discovery continuum from Early Discovery to Lead Identification and Preclinical work, enabling hemodynamic profiling at critical inflection points.

• Discovery Biology: Supports hypothesis testing and pathway clarification through real-time pressure signal analysis.
• Screening: Delivers assay readiness and reproducibility via standardized catheter placement and balloon inflation/deflation cycles.
• Analytics: Provides quantitative dependent variable measurements (pressure waveforms) that enable cross-condition comparison.
• Translational Research: Connects to preclinical continuity through fluoroscopy-guided placement and sustained pulmonary artery positioning.
• Enterprise Reuse: Establishes a reusable capability for cardiovascular model validation across multiple projects.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in cardiovascular pathways.
• Operational Value: Standardization, reproducibility, and scalability of hemodynamic measurements.
• Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk.
• Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on hemodynamic thresholds.

Implementation Considerations

• Required expertise in vascular access and hemodynamic monitoring.
• Instrumentation needs include Swan Ganz catheters, sheaths, guidewires, and fluoroscopy systems.
• Cross-team standardization requires consistent pressure signal interpretation and balloon manipulation protocols.
• Adaptation considerations across model species involve vessel size and anatomical trajectory adjustments.
• Practical limitations include dependence on operator skill for catheter advancement and signal interpretation.

Biopharma FAQs